Skip to content

The study on the comprehensive intervention program of the critical state of blood lipid

The study on the comprehensive intervention program of the critical state of blood lipid

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016578
Enrollment
Unknown
Registered
2018-06-10
Start date
2015-12-01
Completion date
Unknown
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperlipidemia

Interventions

A:dose 1 of red yeast rice
B:dose 2 of red yeast rice
C:dose 2 of red yeast rice

Sponsors

Traditional Chinese Medicine Hospital of Guangdong Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. TC=5.20mmol/L and TC=6.20mmol/L or LDL-C=3.40mmol/L and =4.10mmol/L; 3. Have the complete four methods of diagnosis information; 4. Informed consent.

Exclusion criteria

Exclusion criteria: if any answer as follow is"yes",the subject can't attend this clinical trial: 1. Familial combined hyperlipidaemia; 2. Ccr<60ml/min; 3. Abnormal liver function, ALT, AST or bilirubin greater than 2 times; 4. Hyperlipidemia caused by specific medicines (eg.diuretic,ß-blocker, glucocorticoid, estrin etc.) Or other diseases; 5. Patients with Heart Failure,cardiac function=NYHA IIIand severe arrhythmia (eg.frequent ventricular premature beat,ventricular tachycardia,atrial fibrillation etc.); 6. Uncontrolled 3 grade hypertension(sitting position diastolic pressure=110mmHg or systolic pressure=180mmHg); 7. FPG=15mmol/L; 8. Using heparin,thyroxine and other drugs that affect blood lipid metabolism,or adopted other lipid-lowering measures in 2 weeks; 9. People with severe or unstable heart,liver,kidney,internal secretion,blood etc. medical problems; 10. Mental?diseaseor alcohol or drug dependence; 11. Malignant tumor patient or have relevant history; 12. Be allergic to statins,or have severe adverse reactions history of statins; 13. people with serious gastrointestinal disease,need to be treated now; 14. Pregnant women, lactating women or plan to pregnant during duration of trial or impregnate; 15. Phatient with serious Hypoxic pulmonary disease,such as asthma,chronic bronchitis,COPD; 16. People unwilling to cooperate; 17. Patients who are with bad compliance, not able to be reviewed regularly; 18. Participated in other clinical trials in the last 3 months; 19. Other unsuitable situation discussed by research group.

Design outcomes

Primary

MeasureTime frame
TC;LDL;

Countries

China

Contacts

Public ContactDanping Xu

Guangdong Provincial Hosipital of Chinese Medicine

xudanping@hotmail.com+86 13826406099

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026